Signaturefd LLC increased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 10.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,192 shares of the healthcare conglomerate’s stock after purchasing an additional 578 shares during the quarter. Signaturefd LLC’s holdings in UnitedHealth Group were worth $1,519,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Macquarie Group Ltd. lifted its stake in UnitedHealth Group by 28.7% in the second quarter. Macquarie Group Ltd. now owns 877,919 shares of the healthcare conglomerate’s stock valued at $215,388,000 after acquiring an additional 195,701 shares during the last quarter. Cubist Systematic Strategies LLC lifted its stake in UnitedHealth Group by 28.3% in the second quarter. Cubist Systematic Strategies LLC now owns 31,747 shares of the healthcare conglomerate’s stock valued at $7,789,000 after acquiring an additional 6,996 shares during the last quarter. Flagship Harbor Advisors LLC lifted its stake in UnitedHealth Group by 20.4% in the second quarter. Flagship Harbor Advisors LLC now owns 5,572 shares of the healthcare conglomerate’s stock valued at $1,367,000 after acquiring an additional 944 shares during the last quarter. Tuttle Tactical Management acquired a new stake in UnitedHealth Group in the second quarter valued at $746,000. Finally, OLD Mission Capital LLC acquired a new stake in UnitedHealth Group in the second quarter valued at $300,000. Institutional investors and hedge funds own 85.30% of the company’s stock.
In related news, EVP D Ellen Wilson sold 15,393 shares of the firm’s stock in a transaction dated Friday, August 24th. The shares were sold at an average price of $264.29, for a total transaction of $4,068,215.97. Following the transaction, the executive vice president now directly owns 66,402 shares of the company’s stock, valued at $17,549,384.58. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Steven H. Nelson sold 8,142 shares of the firm’s stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the transaction, the chief executive officer now directly owns 22,496 shares in the company, valued at $5,961,440. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 94,745 shares of company stock worth $24,995,290. 0.87% of the stock is owned by insiders.
Shares of UNH opened at $263.51 on Wednesday. The stock has a market capitalization of $256.66 billion, a PE ratio of 26.17, a P/E/G ratio of 1.59 and a beta of 0.71. UnitedHealth Group Inc has a fifty-two week low of $186.00 and a fifty-two week high of $271.16. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.75 and a current ratio of 0.75.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 EPS for the quarter, topping analysts’ consensus estimates of $3.04 by $0.10. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. The business had revenue of $56.09 billion for the quarter, compared to analyst estimates of $56.10 billion. During the same period last year, the firm earned $2.46 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.1% compared to the same quarter last year. equities research analysts anticipate that UnitedHealth Group Inc will post 12.72 EPS for the current fiscal year.
UnitedHealth Group declared that its board has approved a share repurchase program on Wednesday, June 6th that allows the company to buyback 100,000,000 outstanding shares. This buyback authorization allows the healthcare conglomerate to repurchase shares of its stock through open market purchases. Shares buyback programs are usually an indication that the company’s board believes its shares are undervalued.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 18th. Investors of record on Friday, September 7th were given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date of this dividend was Thursday, September 6th. UnitedHealth Group’s dividend payout ratio is 35.75%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: How is a Moving Average Calculated?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.